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Abstract
Background: Genetic disorders due to kindred marriages are common medical conditions in
Iran; however, the legal aspects of abortion remain controversial. This study was undertaken to
determine physicians' opinions regarding the termination of pregnancy for three genetic diseases:
thalassemia major, hemophilia, and Down's syndrome.
Methods: A questionnaire was administered to selected physicians by stratified random sampling
to determine the following: age, gender, knowledge about prenatal diagnosis of diseases in high risk
pregnancies, agreement with abortion, recommended gestational age for abortion, and, if opposed
to abortion, the reason.
Results: Of 323 physicians, who participated in the study, 91.3(295), 40.6(131), and 78.6%(254)
were in agreement and 8.7(28), 59.4(192), and 21.4%(69) were opposed to abortion for thalassemia
major, hemophilia, and Down's syndrome, respectively. Among 289 physicians opposed to abortion
in respect of each of all three conditions, the following reasons were cited: religion, 18; emotional,
10; quality of care, 23; hope to find a new treatment option in the future, 103; miscellaneous
reasons, 6; and a combination of these reasons, 129. Among 680 physicians in agreement with
abortion in relation to all of the diseases, 4.6%(31) were agreed with abortion in less than 12 weeks
gestation, 79.2%(538) in less than 16 weeks gestation, 5.6%(38) in less than 20 weeks gestation,
2.2%(15) in less than 24 weeks gestation, and 8.4%(58) were agreed with beyond the 24 weeks of
gestational age.
Conclusion: The majority of physicians were in agreement with abortion for thalassemia major
and Down's syndrome because of the overall prognosis, but opposed to abortion for hemophilia.
Background
Genetic disorders are common medical conditions, one of
which is the thalassemia syndrome, a heterogeneous
group of inherited anemias characterized by defects in the
synthesis of one or more of the globin chain subunits of
the hemoglobin tetramer [1]. Thalassemia syndrome is
seen in all ethnic groups and geographic areas, but is most
common in the Mediterranean basin[1]. The so-called
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thalassemia belt extends along the shores of the Mediter-
ranean and throughout the Arabian Peninsula, Turkey,
Iran, India, and southeastern Asia (Thailand, Cambodia,
and southern China) [1]. Skeletal changes, hepatomegaly,
cardiac dilation, small airway obstruction, enlargement of
the kidneys, pigmentory gallstones, and growth retarda-
tion are reported to result from the disease [1]. Hemo-
philia, a sex-linked hereditary coagulopathy, occurs due to
the deficiency of factors VIII and IX (hemophilia A and B,
respectively). The hallmark sign of hemophilia is painful
bleeding into the joints, leading to chronic inflammation
[2].
The most common genetic disease in humans is Down's
syndrome, with an incidence of 1 in 650–700 at birth. It
has a strong association with an increase in maternal age
[3]. Trisomy 21, an additional chromosome of maternal
origin in over 90% of cases, leads to facial, limb, cardiac,
and digestive tract abnormalities [3]. The field of prenatal
diagnosis has emerged and been refined in the past 3 dec-
ades, with techniques that differ in terms of indications,
invasiveness, complications, and risks, such as amniocen-
tesis, [3,4] cordocentesis, [3,4] PGD(Preimplanation
Genetic Diagnosis) [5] and PCR.(Polymerase chain reac-
tion) [6,7].
Other studies by Julian et al. reported 78% acceptance rate
for abortion in Down's syndrome and 21% agreement for
abortion in hemophilia [8].
Up to 10% of families with a child with a genetic disorder
are unable or unprepared to cope with such a child [3-5].
The presence of genetic abnormalities in the fetus in the
majority of developed countries is an acceptable legal
indication for termination of pregnancy [5]. Limitations
of our study was government disagreement with abortion
for all three diseases, thus may be interfere to make deci-
sion of physician regarding abortion in these cases. But
the strength point of study was well familiarity of these
diseases for our physician because they are not rare in
Iran.
This study was undertaken to determine the opinions of
Iranian physicians for termination of pregnancy in moth-
ers with a prenatal diagnosis of thalassemia major, hemo-
philia, and Down's syndrome.
Methods
This cross-sectional and descriptive study was conducted
in southern Iran during 3 months (October to December)
in 2005. A questionnaire was provided (see Additional file
1) to determine the opinions of physicians at Shiraz Uni-
versity of Medical Sciences in Shiraz, Iran regarding abor-
tion for three genetic diseases (thalassemia major,
hemophilia, and Down's syndrome). Age, gender, the fea-
sibility of performing prenatal diagnosis (PND) for
genetic disorders, agreement with abortion, the reasons
for positive response (outcome of the disease, religious
permission of abortion, poor feasibility of treatment,
severity of the disease and Miscellaneous), gestational age
at the time the abortion was recommended, and reasons
(if any) upon which their disagreement with abortion
(emotional, religious, quality of care, and hope for treat-
ment options in the future) was based, were all consid-
ered. This research was approved by the Medical Ethics
Committee of Shiraz University of Medical Sciences. Writ-
ten informed consents were obtained from all physicians.
Of 770 physicians in 10 departments, 384 were selected in
this study anonymously by stratified random sampling.
(P = 0.5, d = 0.05, confident interval=%95) Out of 384,
323 physicians (response rate: 84%) participated in this
study. They were studying in Shiraz University of Medical
Sciences and were belonged to the different parts of Iran.
On the basis of the number of physicians in each ward,
sample size allocated to each ward by stratified random
sampling. They were in 3 degrees: Intern, Resident and
attending. The departments to which the physicians were
attached included Internal Medicine, Surgery, Pediatrics,
Obstetrics and Gynecology, Community Medicine, Psy-
chiatry, Pathology, ENT, Ophthalmology, and Radiology.
Completion of the questionnaire required 20–30 minutes
and it covered the opinion of the responding physician
regarding the view of abortion for thalassemia major,
hemophilia, and Down's syndrome.
All the data were analyzed using SPSS software version
11.5 and chi square Statistical analysis in our qualitative
data was done. The P value less than 0.05 was considered
significant.
Results
Among the respondents, 201 (62.2%) were males and
122 (37.8%) were females. Among them, 164 (50.8%)
were interns, 106 (32.8%) were residents, and 53 (16.4%)
were attending physicians.
Two hundred sixty-one (80.8%), 125 (38.7%), and 171
(52.9%) of the physicians were familiar with the prenatal
diagnosis of thalassemia, hemophilia, and Down's syn-
drome, respectively. Two 295 (91.3%), 131 (40.6%), and
254 (78.6%) physicians were in favor of abortion for tha-
lassemia, hemophilia, and Down's syndrome, respec-
tively, while 28 (8.7%), 192 (59.4%), and 69 (21.4%)
physicians, respectively, were opposed. The most com-
mon reason for agreement in abortion regarding tha-
lassemia major and Down syndrome (72% and 80%
respectively) were poor outcome and prognosis of the dis-
ease.
Among 289 physicians opposed to abortion in respect of
each of all three conditions all of the three conditions, theBMC Medical Ethics 2008, 9:19 http://www.biomedcentral.com/1472-6939/9/19
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following reasons were cited: religion, 18; emotional, 10;
quality of care, 23; hope to find a new treatment option in
the future, 103; miscellaneous reasons, 6; and a combination
of these reasons, 129. Among 680 physicians in agreement
with abortion in relation to all of the diseases, 4.6%(31)
were agreed with abortion in less than 12 weeks gestation,
79.2%(538) in less than 16 weeks gestation,5.6%(38) in less
than 20 weeks gestation, 2.2%(15) in less than 24 weeks ges-
tation, and 8.4%(58) were agreed with beyond the 24 weeks
of gestational age. The results of physicians in agreement
with abortion by gestation for each of all three conditions
(less than 12 weeks gestation, less than 16 weeks gestation,
less than 20 weeks gestation, less than 24 weeks gestation,
and beyond the 24 weeks of gestational age) were evaluated
& were not significant(P > 0.05).
Discussion
Our results showed that 91.3% of physicians agreed with
abortion in the case of a prenatal diagnosis of fetal tha-
lassemia, which the most common reasons were poor out-
come and the severity of the disease, as well as the fact that
thalassemia is a common genetic disorders in Iran and
because of religious legal permission for abortion (Fatwa)
by Ayattolahs before the 16th week of gestation. Acceptabil-
ity of abortion for Down's syndrome among the physicians
was 78.6%, which is in agreement with the same findings
of thalassemia major. Agreement with abortion for hemo-
philia was 40.6%, which is less than thalassemia major and
down syndrome The opposition to abortion for hemo-
philia was nearly similar to the results of other studies [8,9]
showing that the better outcome and prognosis of the dis-
ease do not justify the termination of pregnancy.
In Pakistan, majority of various social groups including
lawyers, parents of thalassemic children and members of
parliament were in favor of genetical diseases and abor-
tion whereas only 24% of doctors favored making genetic
screening [10].
The study showed a twice greater previously reported rate of
willingness by Julian et al. [8] with abortion for hemophilia.
Such a greater rate might be due to treatment and economic
problems in our country. In other studies, the results showed
that most physicians were in favor of abortion in Down's
syndrome which is similar to our result [11].
In the study by Julian et al. [8] 994 physicians participated
in the study and 687 (69%) completed the questionnaire.
They were in agreement with abortion in the first trimester
which is nearly similar to our study (83.8% < 16 weeks of
gestation). Acquiring verbal and written consent for PND
screening to obtain genetic information can disclose
genetic information and genetic anomalies and help par-
ents to overcome controversial issues of therapeutic abor-
tion [12]. Physicians have a legal responsibility to discuss
the implications of PND [13] and provide clear legal
guidelines in their practice. Elkins et al. [14] mentioned
counseling and obtaining informed consent from the
patients for any procedure involving PND. In a study by
Karimi et al. [9] comparing the attitudes towards PND and
termination of pregnancy for hemophilia in Iran and
Italy, 84.7% of the Iranians and 35.4% of the Italians were
not familiar with the possibilities afforded by PND for
hemophilia. Termination of pregnancy appeared to be
accepted by 58.2% of the Iranians and 16.7% of the Ital-
ian participants. The results are different from our study in
relation to hemophilia, however, we evaluated the physi-
cians' views in relation to the acceptability of abortion
and in the study of Karimi et al. [9], the mothers' views
were evaluated. In Iran, we do not have permission to do
abortions in cases of hemophilia, but our physicians hope
to obtain permission to do so in the future.
Conclusion
The majority of our physicians agreed with abortion in
cases of thalassemia major and Down's syndrome. It
Could be due to widespread facilities for PND and poor
outcome for these two diseases as wells as the religious
legal permission of abortion before the 16th week of gesta-
tion in these genetic diseases but in relation to hemo-
philia nearly 60% of participants opposed to abortion
may be due to better prognosis, poor feasibility for PND
and unpermissionable abortion for it.
Limitations
Limitations of our study was government disagreement
with abortion for all three diseases, thus may be interfere
to make decision of physician regarding abortion in these
cases. But the strength point of study was well familiarity
of these diseases for our physician because they are not
rare in Iran.
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